Abstract
To understand the rate-limiting process of oral drug absorption, not only total bioavailability (F) but also intestinal (Fa · Fg) and hepatic (Fh) availability after oral administration should be evaluated. Usually, Fa · Fg of drug is calculated from pharmacokinetic parameters after intravenous and oral administration. This approach is influenced markedly by the estimated value of Fh, which varies with the hepatic blood flow used in the calculations. In this study, portal vein-cannulated rats were used to calculate the Fa · Fg of drugs from a single oral dosing experiment without data from intravenous injection. Portal vein-cannulated rats were prepared by a new operative method that enables stable portal vein blood flow. This surgery had no effects on hepatic blood flow and metabolic activity. Our method for calculating Fa · Fg was validated by determining both portal and systemic plasma concentration profiles of various drugs possessing different pharmacokinetic properties after oral administration to the portal vein-cannulated rats. Simulation of portal and systemic plasma concentrations by physiologically based pharmacokinetic modeling indicated that the balance of the absorption rate constant (ka) and elimination rate constant (ke) resulted in different patterns in portal and systemic plasma concentration-time profiles. This study is expected to provide a new experimental animal model that enables identification of the factors that limit oral bioavailability and to provide pharmacokinetic information on the oral absorption process of drugs during drug discovery.
Footnotes
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
ABBREVIATIONS:
- GI
- gastrointestinal
- PBPK
- physiologically based pharmacokinetic
- IS
- internal standard
- LC
- liquid chromatography
- MS/MS
- tandem mass spectrometry
- α1-AGP
- α1-acid glycoprotein
- AUC
- area under the concentration-time curve.
- Received July 31, 2012.
- Accepted August 28, 2012.
- Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|